NDC 31722-340-10 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 31722-340
- Requested NDC
- 31722-340-10
- Package NDCs from labels
- 31722-340-10, 31722-340-50, 31722-340-01, 31722-340-05
- Manufacturer
- Camber Pharmaceuticals | Invagen Pharmaceuticals
- Effective date
- 2025-09-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - Camber Pharmaceuticals | Invagen Pharmaceuticals | Camber Pharmaceuticals | Invagen Pharmaceuticals | 2025-09-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Naproxen - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2016-07-13 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 31722-340-05 | 2025-09-05 | Naproxen Tablets, USP |
| 31722-340-50 | 2025-09-05 | Naproxen Tablets, USP |
| 31722-340-05 | 2019-11-13 | Naproxen Tablets, USP |
| 31722-340-50 | 2019-11-13 | Naproxen Tablets, USP |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 31722-340-01 | EA - Each | 31722-340 | bf47ff5f-1160-4e16-ace8-389042301228 | 1 | 2012-07-24 |
| 31722-340-05 | EA - Each | 31722-340 | 17eca21a-6b10-4c2c-8197-2f9f6c9b8a3f | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAPROXEN | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN TABLET [CAMBER PHARMACEUTICALS] | 1 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN TABLET [CAMBER PHARMACEUTICALS] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN TABLET [CAMBER PHARMACEUTICALS] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | NAPROXEN TABLET [CAMBER PHARMACEUTICALS] | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | NAPROXEN TABLET [CAMBER PHARMACEUTICALS] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN TABLET [CAMBER PHARMACEUTICALS] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN TABLET [CAMBER PHARMACEUTICALS] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | NAPROXEN TABLET [CAMBER PHARMACEUTICALS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 6573681e-e9be-440f-a818-a533b744648e | 2026-11-09 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | AmerisourceBergen Drug Corporation | f161e151-4fab-2fbc-e053-2a95a90a5437 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | HY-VEE, INC | 415ecfe9-3145-f23e-e063-6394a90adfd8 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2026-11-04 | Warnings | 1K09F3G675 |
| Naproxen | NAPROXEN | REMEDYREPACK INC. | e519fa49-5bd9-405c-a7fb-1403edb8976b | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | REMEDYREPACK INC. | 12202ef3-c65e-45a6-88ed-5d945d8fd41c | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 2d01e583-670a-46f4-b5f2-3fad46d0376f | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | f856d3ff-7e70-4c5a-98fb-76d8af6adb46 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | d8726a3f-03d5-4a5a-a780-f760faaaecf3 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | Granules Pharmaceuticals Inc. | c1cb9bb9-fbae-5e5c-e053-2995a90a0d21 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | St. Mary's Medical Park Pharmacy | 5de3af7c-2c77-6b04-e053-2991aa0ae3fa | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | TruPharma LLC | 004bb832-29d5-add0-e063-6394a90a90f4 | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | Unit Dose Solutions, Inc. | 5ca1d392-ee02-3ce3-e063-6394a90a7827 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Topco Associates LLC | af314adb-bd65-4233-b7e1-6cfb819615a3 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO-TOUCH | Walgreens Company | 33219878-f102-46c6-bd63-e83d54fa2785 | 2026-09-25 | Warnings | 1K09F3G675 |
| Naproxen | NAPROXEN | American Health Packaging | 86a3e612-3bfe-432f-9afd-972bb8a6644e | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | bce23087-f055-4234-b75d-69dd43233190 | 2026-09-23 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.